Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
Aisemberg AC, Wilkes DM, Jacobson JO (1988) The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 71: 969-972
Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835
Anton RC, Brown RW, Younes M, Gondo MM, Stephenson MA, Cagle PT (1997) Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. Hum Pathol 28: 1079-1082
Antonsson B, Martinou J-C (2000) The Bcl-2 protein family. Exp Cell Res 256: 50-57
Apolinario RM, Van Der Valk P, de Jong JS, Deville W, Ark-Otte J, Dingemans AM, Van Mourik JC, Postmus PE, Pinedo HM, Giaccone G (1997) Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 15: 2456-2466
Aupérin A, Arriagada R, Pignon J-P, LePechoux C, Grégor A, Stephens RJ, Kristjansen PEG, Johnson BE, Ueoka H, Wagner H, Aisner J (1999) Prophylactic cranial irradiation for patient with small-cell lung cancer in complete remission. N Engl J Med 341: 476-483
Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL (1996) Apoptosis-related factors p53, bcl-2, and bax in neuroendocrine tumors. Am J Pathol 149: 1941-1952
Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7: 1350-1364
Cappelleri J, Loannidis J, Schmid C, de Ferranti S, Aubert M, Chalmers T, Lau J (1996) Large trials versus meta-analysis of smaller trials. JAMA 276: 1332-1338
Chen Y, Sato M, Fujimura S, Endo C, Sakurada A, Aikawa H, Takahashi H, Tanita T, Kondo T, Saito Y, Sagawa M (1999) Expression of Bcl-2, Bax, and p53 proteins in carcinogenesis of squamous cell lung cancer. Anticancer Res 19: 1351-1356
Choma D, Daures JP, Quantin X, Pujol JL (2001) Aneuploidy and prognosis of non-small cell lung cancer: a meta-analysis of published data. Br J Cancer 85: 14-22
Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R (2000) Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143: 390-400
D'Amico TA, Massey M, Herndon JE, Moore MB, Harpole Jr DH (1999) A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg 117: 736-743
Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G (1999) Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 5: 2048-2058
Dosaka-Akita H, Katabami M, Hommura H, Fujioka Y, Katoh H, Kawakami Y (1999) Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status. Oncology 56: 259-264
Eerola AK, Ruokolainen H, Soini Y, Raunio H, Paakko P (1999) Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung. Pathol Oncol Res 5: 179-186
Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G (1997) Language bias in randomised controlled trials published in English and German. Lancet 350: 326-329
Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angelettl CA, Basolo F, Bevilacqua G (1995) Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 71: 1003-1007
Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Chine S, Angeletti CA, Bevilacqua G (1996) Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res 2: 1067-1075
Ghosh M, Crocker J, Morris AG (1999) CD40 and bcl-2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, survival, and other clinicopathological factors. J Pathol 189: 363-367
Greatens TM, Niehans GA, Rubins JB, Jessurun J, Kratzke RA, Maddaus MA, Niewoehner DE (1998) Do molecular markers predict survival in non-small-cell lung cancer? Am J Respir Crit Care Med 157: 1093-1097
Higashiyama M, Doi O, Kodama K, Yokouchi H, Nakamori S, Tateishi R (1997) bcl-2 Oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J Surg Oncol 64: 48-54
Hockenbery D, Numez G, Milliman C, Schreiber RD, Korsmeyer S (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334
Huang C, Kohno N, Inufusa H, Kodama K, Taki T, Miyake M (1999) Overexpression of bax associated with mutations in the loop-sheet-helix motif of p53. Am J Pathol 155: 955-965
Ishida H, Irie K, Itoh T, Furukawa T, Tokunaga O (1997) The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer 80: 1034-1045
Jong D, Prins FA, Masson DY, Reed JC, Van Ommen GB, Kluin PM (1994) Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res 54: 256-260
Kaiser U, Schilli M, Haag U, Neumann K, Kreipe H, Kogan E, Havemann K (1996) Expression of bcl-2 protein in small cell lung cancer. Lung Cancer 15: 31-40
Kanters SD, Lammers JW, Voest EE (1995) Molecular and biological factores in the prognosis of non-small cell lung cancer. Eur Respir J 8: 1389-1397
Kim YC, Park KO, Kern JA, Park CS, Lim SC, Jang AS, Yang JB (1998) The interactive effect of Ras, HER2, p53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer 22: 181-190
Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Whitehouse RM, Talbot DC, Gatter KC, Harris AL (1997) Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer 74: 565-570
Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3: 614-620
Kwiatkowski DJ, Harpole Jr DH, Godleski J, Herndon JE, Shieh DB, Richards W, Blanco R, Xu HJ, Strauss GM, Sugarbaker DJ (1998) Molecular pathologic substaging in 244 stage I non-small cell lung cancer patients: clinical implications. J Clin Oncol 16: 2468-2477
Laudanski J, Chyczewski L, Niklinska WE, Kretowska M, Furman M, Sawicki B, Niklinski J (1999) Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Neoplasma 46: 25-30
Le Brun DP, Warnke RA, Cleary ML (1993) Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142: 743
Lee JS, Yoon A, Kalapurakal SK, Ro JY, Lee JJ, Tu M, Hittelman WN, Hong WK (1995) Expression of p53 oncoprotein in non-small cell lung cancer: a favorable pronostic factor. J Clin Oncol 13: 1893-1903
Luce S, Paesmans M, Berghmans T, Castaigne C, Sotiriou C, Vermylen P, Sculier J-P (1998) Revue critique des études randomisées évaluant le rôle de la radiothérapie dans le traitement du cancer bronchique à petites cellules au stade limité. Rev Mal Respir 15: 633-641
Maitra A, Amirkhan RH, Saboorian MH, Frawley WH, Ashfaq R (1999) Survival in small cell lung carcinoma is independent of Bcl-2 expression. Hum Pathol 30: 712-717
Mascaux C, Paesmans M, Berghmans T, Branle F, Lafitte J-J, Lemaitre F, Meert A-P, Vermylen P, Sculier J-P (2000) A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 30: 23-36
Meert A-P, Berghmans T, Branle F, Lemaître F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier J-P (1999) Phase II et III with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment. Anticancer Res 19: 4379-4390
Meert A-P, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout J-M, Lafitte J-J, Sculier J-P (2001) Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 1: 5
Mulrow CD (1987) The medical review article: state of the Science. Ann Intern Med 106: 485-488
O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL (2000) Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer. Br J Cancer 82: 1427-1432
O'Neill AJ, Staunton MJ, Gaffney EF (1996) Apoptosis occurs independently of bcl-2 and p53 over-expression in non-small cell lung carcinoma. Histopathology 29: 45-50
Ohsaki Y, Toyoshima E, Fujiuchi S, Matsui H, Hirata S, Miyokawa N, Kubo Y, Kikuchi K (1996) Bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin Cancer Res 2: 915-920
Paesmans M, Sculier J-P, Lecomtre J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Custem O, Mommen P, Ninane V, Klastersky J, for the European Lung Cancer Working Party (2000) Prognostic factors in patients with small cell lung cancer: analysis of a series of 763 patients included in four consecutive prospective trials and with a minimal 5-year follow-up duration. Cancer 89: 523-533
Paesmans M, Sculier J-P, Libert P, Bureau G, Dabouis G, Thiriaux J, Michel J, Van Custem O, Sergysels R, Mommen P (1995) Prognostic factors for survival in advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. J Clin Oncol 13: 1221-1230
Paesmans M, Sculler J-P (1998) Facteurs pronostiques des cancers bronchopulmonaires. In Cancer Broncho-pulmonaires, Milleron B, Depierre A (eds) pp 239-247. Arnette F-78141 Velizy-Villacoublay, France
Parmar, Mahesh KB, Torri V, Stewart L (1998) Extracting summary statistics to perfom meta-analyses of the published literature for survical endpoinds. Statist Med 17: 2815-2834
Pastorino U, Andreola S, Tagliabue E, Pezzella F, Incarbone M, Sozzi G, Buyse M, Menard S, Pierotti M, Rilke F (1997) Immunocytochemical markers in stage I lung cancer: relevance to prgnosis. J Clin Oncol 15: 2858-2865
Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Garter KC, Mason DY (1993) bcl-2 Protein in non-small-cell lung carcinoma [see comments]. N Engl J Med 329: 690-694
Pujol JL (1997) Cyfra 21-1. Rev Mal Respir 14: 3s31-3s36
Rao SK, Krishna M, Woda BA, Savas L, Fraire AE (1996) Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung. Mod Pathol 9: 555-559
Santinelli A, Ranaldi R, Baccarini M, Mannello B, Bearzi I (1999) Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. Pathol Res Pract 195: 467-474
Sculier J-P, Berghmans T, Castaigne C, Luce S, Sotiriou C, Vermylen P, Paesmans M (1998) Maintenance chemotherapy for small cell lung cancer: a critical review of the literature. Lung Cancer 19: 141-151
Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U (1994) The bcl-2: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86: 499-504
Steels E, Paesmans M, Berghmans T, Branle F, Burniat A, Ghisdal L, Lafitte J-J, Lemaitre F, Mascaux C, Meert A-P, Vallot F, Sculier J-P (2001) Role of p53 on the survival of patients with lung cancer as assessed by a systematic review of the literature. Eur Respir J 18: 705-719
Stewart A, Parmar K (1993) Meta-analysis of the literature or of individual patient data 1 is there a difference? Lancet 341: 418-422
Strauss GM (1997) Prognostic markers in resectable non-small cell lung cancer. Hematol Oncol Clin North Am 11: 409-434
Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, Sugarbaker DJ (1995) Molecular and pathologic analysis of stade I non-small cell lung carcinoma of the lung. J Clin Oncol 13: 1265-1279
Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N (1996) Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer. Cancer J Sci Am 2: 212-216
Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts and protein products of Bcl-2 the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 5214-5218
Walker C, Robertson L, Myskow M, Dixon G (1995) Expression of the Bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 72: 164-169
Yip D, Harper PG (2000) Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer 28: 173-185
Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27: 335-371
